Indiana Biosciences Research Institute
An independent translational research institute that convenes academic, industry and public partners to develop patient-informed solutions for diabetes, cardiometabolic disease, neurodegeneration and related areas. Operates collaborative research centers and core facilities focused on data science, bioanalytical technologies, single-cell analysis, and pharmaceutical biotechnology to advance discovery, preclinical candidate development and early-stage translational projects.
Industries
N/A
Products
Open toxicogenomics web portal
A web-accessible analytics portal that integrates mechanistic and toxicogenomic study results to predict longer-term toxicity from short-duration gene expression changes.
Single-cell rare-cell analysis platform (research prototype)
A research-stage platform combining microfluidic sample handling, nanoparticle chemistries and mass spectrometric readouts to detect and analyze rare cells from whole blood and clinical samples.
Open toxicogenomics web portal
A web-accessible analytics portal that integrates mechanistic and toxicogenomic study results to predict longer-term toxicity from short-duration gene expression changes.
Single-cell rare-cell analysis platform (research prototype)
A research-stage platform combining microfluidic sample handling, nanoparticle chemistries and mass spectrometric readouts to detect and analyze rare cells from whole blood and clinical samples.
Services
Peptide synthesis for discovery projects
Peptide production using in-house synthesis instrumentation to support discovery-stage chemistry and screening.
Open toxicogenomics analytics platform (early risk assessment)
Shared analytics platform for integrating toxicogenomic datasets and mechanistic study results to accelerate early compound safety decisions.
Single-cell and rare-cell analysis development services
Development and validation of single-cell assays and rare-cell detection workflows combining microfluidics, nanoparticle reagents and mass spectrometry.
Peptide synthesis for discovery projects
Peptide production using in-house synthesis instrumentation to support discovery-stage chemistry and screening.
Open toxicogenomics analytics platform (early risk assessment)
Shared analytics platform for integrating toxicogenomic datasets and mechanistic study results to accelerate early compound safety decisions.
Single-cell and rare-cell analysis development services
Development and validation of single-cell assays and rare-cell detection workflows combining microfluidics, nanoparticle reagents and mass spectrometry.
Expertise Areas
- Translational research and industry-academic partnerships
- Real-world data analytics and clinical informatics
- Toxicogenomics and predictive toxicology
- Single-cell analytics and rare-cell detection
Key Technologies
- Mass spectrometry
- Microfluidics
- Single-cell analysis
- BioMEMs (microelectromechanical systems)